Cardiologia
Revisão | Diagnóstico e tratamento da hipertensão arterial pulmonar.
14 Abr, 2022 | 17:48hDiagnosis and Treatment of Pulmonary Arterial Hypertension: A Review – JAMA (gratuito por tempo limitado)
Revisão clínica em áudio: Diagnosis and Treatment of Pulmonary Arterial Hypertension – JAMA
Comentário no Twitter
This review summarizes current evidence regarding diagnosis and treatment of pulmonary arterial #hypertension. https://t.co/Ebo33PD8Qq
— JAMA (@JAMA_current) April 12, 2022
M-A | Inibidores de SGLT2 estão associados com risco reduzido de hiperpotassemia em pessoas com diabetes tipo 2.
14 Abr, 2022 | 17:44hEstudo de coorte | Diâmetro aumentado da aorta torácica está associado com risco aumentado de eventos cardiovasculares e mortalidade entre mulheres e homens.
14 Abr, 2022 | 17:34hThoracic Aortic Diameter and Cardiovascular Events and Mortality among Women and Men – Radiology
Comunicado de imprensa: Increased aortic diameter raises risk of heart attack, stroke – Radiological Society of North America
Interação entre antagonistas do receptor de mineralocorticoide e empagliflozina na insuficiência cardíaca: análise secundária do estudo EMPEROR-Reduced.
14 Abr, 2022 | 17:27hEditorial: Quadruple Medical Therapy for Heart Failure: Medications Working Together to Provide the Best Care
Breve revisão | Endocardite infecciosa: pontos de atenção no tratamento.
14 Abr, 2022 | 17:26hInfective Endocarditis: Words of Caution For Management – American College of Cardiology
Conteúdos relacionados:
Randomized Trial: Partial Oral vs. Intravenous Antibiotic Treatment of Endocarditis
Podcast: Infective Endocarditis Pearls.
Review: Infective endocarditis after surgical and transcatheter aortic valve replacement
Infective Endocarditis: A Contemporary Review
Summary: Current AATS Guidelines on Surgical Treatment of Infective Endocarditis
Review: Current Evidence on Oral Antibiotics for Infective Endocarditis
Research: Invasive Procedures Associated With the Development of Infective Endocarditis
Prosthetic Valve Endocarditis After Surgical Aortic Valve Replacement
Estudo identifica quais tratamentos estão associados com risco aumentado de doença cardíaca entre mulheres com câncer de mama.
14 Abr, 2022 | 17:20hRisk of Cardiovascular Disease in Women With and Without Breast Cancer: The Pathways Heart Study – Journal of Clinical Oncology (link para o resumo – $ para o texto completo)
Comentário: Major study links breast cancer treatment with increased risk of cardiovascular disease – Fred Hutch
Comentário no Twitter
Great case-control study in a modern cohort evaluating long-term cardiovascular disease after #breastcancer treatment. HR for heart failure/cardiomyopathy higher for anthracyclines (HR=1.84) and herceptin (HR=2.53) than for #radiotherapy (HR=1.38). #bcsmhttps://t.co/ZEVfbwlepr
— Shane Stecklein, MD, PhD (@shanestecklein) April 8, 2022
Revisão | Intervenção coronariana percutânea (ICP) em pacientes com insuficiência cardíaca: evidências atuais, impacto da revascularização completa e técnicas contemporâneas para melhorar os desfechos.
14 Abr, 2022 | 17:18h
Comentário no Twitter
#PCI in Patients With #HeartFailure: Current Evidence,Impact of Complete Revascularization, and Contemporary Techniques to Improve Outcomeshttps://t.co/cMKIByKN7n @GreggWStone @MVMadhavanMD @ericjvelazquez @mmamas1973 @mirvatalasnag @AndrewJSauer @ShelleyZieroth @DrMarthaGulati pic.twitter.com/3A9BWwD7Gc
— Henry Han, MBBS, MD (@HanCardiomd) April 9, 2022
(Imagens e artigo sob licença de CC BY 4.0)
Estudo randomizado | Rivaroxabam profilático por 30 dias para prevenir trombo ventricular esquerdo após infarto do miocárdio com elevação do segmento ST.
14 Abr, 2022 | 17:17hProphylactic Rivaroxaban Therapy for Left Ventricular Thrombus After Anterior ST-Segment Elevation Myocardial Infarction – JACC: Cardiovascular Interventions (link para o resumo – $ para o texto completo)
M-A | Inibidores de SGLT2 reduzem internações em pacientes com insuficiência cardíaca independentemente da presença de diabetes.
14 Abr, 2022 | 17:02hSodium–Glucose Cotransporter-2 Inhibitors in Patients With Heart Failure: A Systematic Review and Meta-analysis – Annals of Internal Medicine (link para o resumo – $ para o texto completo)
Comunicado de imprensa: SGLT2 inhibitors reduces hospitalization for heart failure regardless of presence of diabetes – American College of Physicians
Diretriz científica AHA | Infecção por SARS-CoV-2 e manifestações cardiovasculares associadas em crianças e jovens adultos.
14 Abr, 2022 | 16:59hComunicado de imprensa: Heart issues after COVID-19 uncommon in children and young adults, more research needed – American Heart Association
Comentário: COVID-19 CV Complications in Children Are Rare, Treatable: AHA Statement – TCTMD


